英文别名 |
Entospletinib (GS-9973);GS-9973;6-(1H-indazol-6-yl)-N-(4-morpholin-4-ylphenyl)imidazo[1,2-a]pyrazin-8-amine;6-(1H-indazol-6-yl)-N-(4-morpholinophenyl)imidazo[1,2-a]pyrazin-8-amine;Entospletinib;Entospletinib (GS-9973);GS9973;Entospletinib [INN];S7523;UNII-6I3O3W6O3B;6-(1H-Indazol-6-yl)-N-[4-(4-morpholinyl)phenyl]imidazo[1,2-a]pyrazin-8-amine;GS 9973;Imidazo[1,2-a]pyrazin-8-amine, 6-(1H-indazol-6-yl)-N-[4-(4-morpholinyl)phenyl]-;BDBM50015448;CCG-264700;BRD-K76719364-001-04-1;NSC-800988;MFCD28099806;4puz;1229208-44-9;ENTOSPLETINIB [USAN];AKOS027295322;6-(1H-Indazol-6-yl)-N-(4-morpholinophenyl)imidazo[1,2-a]pyrazin-8-amine;BRD-K76719364-001-02-5;ENTOSPLETINIB [WHO-DD];NSC800988;D11209;Entospletinib [USAN:INN];HMS3673E05;HY-15968;EX-A1120;AS-17026;NS00073149;SB16830;SW220048-1;GS 9973; 6-(1H-Indazol-6-yl)-N-[4-(4-morpholinyl)phenyl]-Imidazo[1,2-a]pyrazin-8-amine;;NCGC00378596-07;6-(2H-indazol-6-yl)-N-[4-(morpholin-4-yl)phenyl]imidazo[1,2-a]pyrazin-8-amine;s7523;J-690079;Imidazo(1,2-a)pyrazin-8-amine, 6-(1H-indazol-6-yl)-N-(4-(4-morpholinyl)phenyl)-;Entospletinib (USAN/INN);DTXSID001317670;6I3O3W6O3B;HMS3653D13;NSC-781516;BRD-K76719364-001-01-7;NSC781516;6-(1h-Indazol-6-Yl)-N-[4-(Morpholin-4-Yl)phenyl]imidazo[1,2-A]pyrazin-8-Amine;SYK INHIBITOR GS-9973;GS9973Entospletinib;GS-9973; Entospletinib;SCHEMBL2483776;CHEMBL3265032;BCP09582;Q27077193;DB12121;6-Cyclopropyl-8-fluoro-2-[2-(hydroxymethyl)-3-(1-methyl-5-{[5-(4-methyl-1-piperazinyl)-2-pyridinyl]amino}-6-oxo-1,6-dihydro-3-pyridi nyl)phenyl]-1(2H)-isoquinolinone;6-(1H-Indazol-6-yl)-N-(4-(morpholin-4-yl)phenyl)imidazo(1,2-a)pyrazin-8-amine;GTPL7889;gs9973;AC-30236;DA-36929;GS9973Entospletinib?;HMS3750E13 |